BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
QuintilesIMS
Express Scripts
Argus Health
Accenture
Colorcon
Cipla
Medtronic
US Army
Teva

Generated: January 16, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018554

« Back to Dashboard

NDA 018554 describes EULEXIN, which is a drug marketed by Schering and is included in one NDA. Additional details are available on the EULEXIN profile page.

The generic ingredient in EULEXIN is flutamide. There are eleven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the flutamide profile page.
Summary for 018554
Tradename:EULEXIN
Applicant:Schering
Ingredient:flutamide
Patents:0
Therapeutic Class:Hormonal Agents, Suppressant (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 018554

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength125MG
Approval Date:Jan 27, 1989TE:RLD:Yes

Expired US Patents for NDA 018554

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Schering EULEXIN flutamide CAPSULE;ORAL 018554-001 Jan 27, 1989 ➤ Subscribe ➤ Subscribe
Schering EULEXIN flutamide CAPSULE;ORAL 018554-001 Jan 27, 1989 ➤ Subscribe ➤ Subscribe
Schering EULEXIN flutamide CAPSULE;ORAL 018554-001 Jan 27, 1989 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Federal Trade Commission
Colorcon
AstraZeneca
Argus Health
Teva
QuintilesIMS
Daiichi Sankyo
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot